Carregant...
Bisphosphonate therapy for osteogenesis imperfecta
BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which typically results in multiple fractures with little or no trauma. Bisphosphonates are used in an attempt to increase bone mineral density and reduce these fractures in people...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2016
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611487/ https://ncbi.nlm.nih.gov/pubmed/27760454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005088.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|